Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Diabetes

• Publication date

  2014-12-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/db14-1225PMID 25552600
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity

  2014cited by this paper
• Diabetes

  2013cited by this paper
• Activation of Sterol Regulatory Element Binding Protein and NLRP3 Inflammasome in Atherosclerotic Lesion Development in Diabetic Pigs

  2013cited by this paper
• β-Carotene Attenuates Angiotensin II-Induced Aortic Aneurysm by Alleviating Macrophage Recruitment in Apoe−/− Mice

  2013cited by this paper
• A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats

  2013cited by this paper
• AICAR inhibits PPARγ during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids.

  2013cited by this paper
• AMPK: a nutrient and energy sensor that maintains energy homeostasis

  2012cited by this paper
• RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity.

  2012cited by this paper
• Dyslipidemia Associated with Poor Glycemic Control in Type 2 Diabetes Mellitus and the Protective Effect of Metformin Supplementation

  2012cited by this paper
• IL-1R–Associated Kinase-1 Mediates Protein Kinase Cδ-Induced IL-1β Production in Monocytes

  2011cited by this paper
• Macrophages in the pathogenesis of atherosclerosis.

  2011cited by this paper
• AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3)

  2010cited by this paper
• The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages

  2010cited by this paper
• Macrophage α1 AMP-activated Protein Kinase (α1AMPK) Antagonizes Fatty Acid-induced Inflammation through SIRT1*

  2010cited by this paper
• AMPK in Health and Disease.

  2009cited by this paper
• Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype1

  2008influential reference
• Reference

  2008cited by this paper
• Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase*

  2007cited by this paper
• The immune response in atherosclerosis: a double-edged sword

  2006influential reference
• Strobilocercus fasciolaris infection with hepatic sarcoma and gastroenteropathy in a Wistar colony.

  2006cited by this paper
• AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.

  2005cited by this paper
• α-Lipoic Acid Prevents Endothelial Dysfunction in Obese Rats via Activation of AMP-Activated Protein Kinase

  2005cited by this paper
• Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase.

  2005cited by this paper
• Vitamin E Inhibits Abdominal Aortic Aneurysm Formation in Angiotensin II–Infused Apolipoprotein E–Deficient Mice

  2004cited by this paper
• Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes.

  2004cited by this paper
• Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.

  2004cited by this paper
• AMP-activated Protein Kinase Is Required for the Lipid-lowering Effect of Metformin in Insulin-resistant Human HepG2 Cells*

  2004cited by this paper
• The macrophage foam cell as a target for therapeutic intervention

  2002cited by this paper
• Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.

  2002cited by this paper
• Biomechanical Strain Induces Class A Scavenger Receptor Expression in Human Monocyte/Macrophages and THP-1 Cells: A Potential Mechanism of Increased Atherosclerosis in Hypertension

  2001cited by this paper
• STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation.

  2001cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

  2000cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL.

  1998cited by this paper

• Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases

  2026cites this paper
• Role and mechanisms of vascular smooth muscle cell phenotypic transition in diabetic macrovascular complications

  2026cites this paper
• A pH/glucose dual-responsive Janus dressing with optimized gradient modulus/tissue adhesion promotes diabetic wound healing by dynamic drug-payload release

  2026cites this paper
• Investigation of exercise-mimetic bioactive molecules as modulators of MMP activity and expression in cancer cells

  2026cites this paper
• Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model.

  2026cites this paper
• Metformin Mitigates Diabetes-Driven Renal Senescence via Immunomodulation and the FABP4/FOXO1 Axis

  2025cites this paper
• Metformin-mechanisms of its glycemia-reducing effect.

  2025cites this paper
• Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches

  2025cites this paper
• Causal association of metformin treatment with diverse immune-mediated inflammatory diseases: A Mendelian randomization analysis

  2025cites this paper
• The chemical composition analysis of Yixin Tongmai Granules using UHPLC-MS/MS and exploration of its potential mechanism in treatment of coronary artery disease based on network pharmacology and molecular docking

  2025cites this paper
• Reprogram to heal: Macrophage phenotypes as living therapeutics.

  2025cites this paper
• Immunoregulatory effect of metformin in monocytes exposed to SARS-CoV-2 spike protein subunit 1

  2025cites this paper
• The role of doxycycline in reducing MMP-9 and acute-phase reactants to limit abdominal aortic aneurysm growth: A systematic review.

  2025cites this paper
• "Expression of the Peroxisome Proliferators-Activated Receptors (PPARs) in ex vivo arterial tissue of patients with abdominal aneurysms and its association with wall remodeling and inflammatory gene expression".

  2025cites this paper
• Emerging in Diabetic Cardiomyopathy: Molecular Pathways and Targets for Therapeutic Intervention

  2025cites this paper
• From Diabetes to Degenerative Diseases: The Multifaceted Action of Metformin

  2025cites this paper
• EXPRESS: Metformin; Its Salutary Effects Beyond Diabetes Mellitus.

  2025cites this paper
• Immunosenescence: signaling pathways, diseases and therapeutic targets

  2025cites this paper
• Metformin prevents diabetes development in type 1 diabetes models via suppression of mTOR and STAT3 signaling in immune cells

  2025cites this paper
• Metformin attenuates alveolar bone destruction in mice with apical periodontitis and inhibits pro-inflammatory cytokine synthesis in lipopolysaccharide-stimulated RAW264.7 through the AMPK-mTOR-NF-κB pathway

  2025cites this paper
• Metabolic Homeostasis of Immune Cells Modulates Cardiovascular Diseases

  2025cites this paper
• THE POTENTIAL ROLE OF METFORMIN IN THE TREATMENT OF HASHIMOTO’S THYROIDITIS: REVIEW

  2025cites this paper
• Metformin Against Herpes Zoster in Colon Cancer Patients with Type 2 Diabetes: A PSM Analysis

  2025cites this paper
• Independent and Combined Impacts of Obesity and Aging on Chronic Kidney Disease

  2025cites this paper
• Analyzing the Structure-Activity Relationship of Necrostain-1 and Its Analogues as RIPK1 Inhibitors on Necroptosis

  2025cites this paper
• Metformin ablates high fat diet-induced skeletal muscle hypertrophy and elevation of sarcolemmal GLUT4 when feeding is initiated in young adult male mice

  2025cites this paper
• Bibliometric analysis of metformin as an immunomodulator (2013–2024)

  2025cites this paper
• Metformin-mediated protection against Immunosenescence in diabetic cardiomyopathy: The potential roles of GDF-15 and klotho proteins.

  2025cites this paper
• The potential of a nomogram risk assessment model for the diagnosis of abdominal aortic aneurysm: a multicenter retrospective study

  2024cites this paper
• A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells

  2024cites this paper
• Exploring the diverse therapeutic benefits of metformin: from anti-cancer to anti-inflammation and PCOS management

  2024cites this paper
• Metformin's cardioprotective role in isoprenaline-induced myocardial infarction: Unveiling insights into the AMPK, NF-κB, JAK2/STAT3 pathways, and cholinergic regulation.

  2024cites this paper
• Delaying Renal Aging: Metformin Holds Promise as a Potential Treatment

  2024cites this paper
• Human Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions

  2024cites this paper
• Metformin in gestational diabetes: physiological actions and clinical applications

  2024cites this paper
• DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects

  2024cites this paper
• Macrophage iron dyshomeostasis promotes aging‐related renal fibrosis

  2024cites this paper
• Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study.

  2024cites this paper
• Pharmacological therapy targeting the immune response in atherosclerosis.

  2024cites this paper
• Metformin Attenuates Neutrophil Recruitment through the H3K18 Lactylation/Reactive Oxygen Species Pathway in Zebrafish

  2024cites this paper
• Therapeutic JAK1 Inhibition Reverses Lupus Nephritis in a Mouse Model and Demonstrates Transcriptional Changes Consistent With Human Disease

  2024cites this paper
• Network pharmacology-based approach to understand the effect and mechanism of Tangzhiqing against atherosclerosis

  2024cites this paper
• Inspiring Tactics with the Improvement of Mitophagy and Redox Balance for the Development of Innovative Treatment against Polycystic Kidney Disease

  2024cites this paper
• Association of metformin use with abdominal aortic aneurysm: A systematic review and meta-analysis

  2024cites this paper
• Functional significance of DNA methylation: epigenetic insights into Sjögren’s syndrome

  2024cites this paper
• Understanding the action mechanisms of metformin in the gastrointestinal tract

  2024cites this paper
• Mitochondria-targeted esculetin and metformin delay endothelial senescence by promoting fatty acid β-oxidation: Relevance in age-associated atherosclerosis.

  2024cites this paper
• Metabolic Adaptations and Functional Activity of Macrophages in Homeostasis and Inflammation

  2024cites this paper
• Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS‐010759

  2024cites this paper
• Targeting the lung tumor microenvironment by phytochemicals and their nanoformulations.

  2024cites this paper
• The antiprotozoal drug nitazoxanide improves experimental liver fibrosis in mice.

  2024cites this paper
• Metabolic changes and functional activity of macrophages in homeostasis and in inflammation (review)

  2024cites this paper
• Developmental trajectories of atopic dermatitis with multi-omics approaches in the infant gut: COCOA birth cohort.

  2024cites this paper
• Paolo Brambilla, PhD, MD Possible role of metformin as an antidepressant in diabetes. Review.

  2024cites this paper
• Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular disease

  2023cites this paper
• Mechanisms and efficacy of metformin-mediated suppression of established experimental abdominal aortic aneurysms

  2023cites this paper
• Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?

  2023cites this paper
• Metformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review

  2023cites this paper
• Myeloid Cells As a Promising Target for Brain–Bone Degenerative Diseases from a Metabolic Point of View

  2023cites this paper
• Molecular mechanisms of action of metformin: latest advances and therapeutic implications

  2023cites this paper
• Signaling through the IL-6-STAT3 Pathway Promotes Proteolytically-Active Macrophage Accumulation Necessary for Development of Small AAA

  2023cites this paper
• Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes

  2023cites this paper
• Research progress of metformin in the treatment of liver fibrosis.

  2023cites this paper
• ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-κB/ATF5 pathway.

  2023cites this paper
• Metformin adherence and the risk of cardiovascular disease: a population-based cohort study

  2023cites this paper
• RRP Regulates Autophagy through the AMPK Pathway to Alleviate the Effect of Cell Senescence on Atherosclerosis

  2023cites this paper
• Qinling liquid ameliorates renal immune inflammatory damage via activating autophagy through AMPK/Stat3 pathway in uric acid nephropathy.

  2023cites this paper
• Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma.

  2023cites this paper
• Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction

  2023cites this paper
• AMPK signaling inhibits the differentiation of myofibroblasts: impact on age-related tissue fibrosis and degeneration

  2023cites this paper
• Macrophage Polarization and Signaling in Diabetic Kidney Disease: A Catalyst for Disease Progression.

  2023cites this paper
• Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanism

  2023cites this paper
• Multi-faceted roles of C1q/TNF-related proteins family in atherosclerosis

  2023cites this paper
• Role of miR‐15a‐5p and miR‐199a‐3p in the inflammatory pathway regulated by NF‐κB in experimental and human atherosclerosis

  2023cites this paper
• Evaluation of PEN2-ATP6AP1 axis as an antiparasitic target for metformin based on phylogeny analysis and molecular docking.

  2023cites this paper
• Hyaluronic acid-graphene oxide quantum dots nanoconjugate as dual purpose drug delivery and therapeutic agent in meta-inflammation

  2023cites this paper
• Macrophage AMPK β1 activation by PF-06409577 reduces the inflammatory response, cholesterol synthesis, and atherosclerosis in mice

  2023cites this paper
• Novel pharmacological approaches in abdominal aortic aneurysm

  2023cites this paper
• Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis

  2023cites this paper
• Nek6 knockdown polarized macrophages into a pro‐inflammatory phenotype via inhibiting STAT3 expression

  2023cites this paper
• Mechanisms of neutrophil extracellular trap in chronic inflammation of endothelium in atherosclerosis.

  2023cites this paper
• Leukocyte-Specific Morrbid Promotes Leukocyte Differentiation and Atherogenesis

  2023cites this paper
• Why Metformin Should Not Be Used as an Oxidative Phosphorylation Inhibitor in Cancer Patients

  2023cites this paper
• Vinpocetine alleviates intestinal ischemia/reperfusion injury and enhances M2 macrophage polarization in rats: Role of SIRT1/SOCS3/STAT3 signaling pathway.

  2023cites this paper
• Type 2 diabetes has a protective causal association with thoracic aortic aneurysm: a Mendelian randomization study

  2023cites this paper
• Metformin increases the expression of proinflammatory cytokines and inhibits supraspinatus fatty infiltration

  2023cites this paper
• Signaling pathways and intervention for therapy of type 2 diabetes mellitus

  2023cites this paper
• Novel Leflunomide Analog, UTLOH-4e, ameliorates gouty arthritis induced by monosodium urate via NF.

  2023cites this paper
• Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation

  2023cites this paper
• The Role and Mechanism of Metformin in Inflammatory Diseases

  2023cites this paper
• Cardiovascular Protection by Metformin: Latest Advances in Basic and Clinical Research

  2023cites this paper
• Treatment With Small Molecule Inhibitors of Advanced Glycation End‐Products Formation and Advanced Glycation End‐Products‐Mediated Collagen Cross‐Linking Promotes Experimental Aortic Aneurysm Progression in Diabetic Mice

  2023cites this paper
• Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway

  2023cites this paper
• Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK

  2022cites this paper
• Nanotechnology in Metformin Delivery: Fasting Blood Sugar and Neutrophil-Lymphocyte Ratio of Diabetic Rat Model

  2022cites this paper
• Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging

  2022cites this paper
• A Network Pharmacology Study to Explore the Underlying Mechanism of Safflower (Carthamus tinctorius L.) in the Treatment of Coronary Heart Disease

  2022cites this paper
• AMPK integrates metabolite and kinase-based immunometabolic control in macrophages

  2022cites this paper
• Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study

  2022cites this paper
• Anti-hyperglycemic contours of Madhugrit are robustly translated in the Caenorhabditis elegans model of lipid accumulation by regulating oxidative stress and inflammatory response

  2022cites this paper